Collegium to Present at Upcoming Investor Conference
September 28 2018 - 2:16PM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today announced that
management will present at the following investor conference in
October:
- The Cantor Global Healthcare Conference on Tuesday, October 2nd
at 2:50 p.m. ET in New York City
About Collegium Pharmaceutical,
Inc.
Collegium is a specialty pharmaceutical company focused on
becoming the leader in responsible pain management by developing
and commercializing innovative and differentiated products for
people suffering from pain and our communities.
About Xtampza ER
Xtampza® ER is Collegium’s first product utilizing the DETERx
technology platform. Xtampza ER is an abuse-deterrent,
extended-release, oral formulation of oxycodone approved by the FDA
for the management of pain severe enough to require daily,
around-the-clock, long-term opioid treatment and for which
alternative treatment options are inadequate.
Contact: Alex Dasallaadasalla@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Mar 2024 to Apr 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Apr 2023 to Apr 2024